$USD
  • €EUR
  • $USD
  • £GBP
Search

Cart

Loadding...
Home>Peptides>Tesamorelin 2mg/vial 5mg/vial
Tesamorelin  2mg/vial 5mg/vial

Tesamorelin 2mg/vial 5mg/vial

$USD 80.30
specification
2mg/vial 10vials 2mg/vial 20vials 2mg/vial 50vials 2mg/vial 100vials 5mg/vial 10vials 5mg/vial 20vials 5mg/vial 50vials 5mg/vial 100vials

couriers: Royal Mail, Fedex, UPS, DHL, DPD etc.

payment method: pay by Paypal, Debit&Credit Card online.


Contact us for other payment methods: Apple Pay, Google Pay, Bank Transfer, Western Union, Money Gram, USDT and Bitcoin.

WhatsApp: +8613207152765


Telegram: t.me/barry2765



Copy and share this link on social network or send it to your friends

Copy
Adding to cart succeed
Tesamorelin 2mg/vial 5mg/vial
color:red,size:xxl
Subtotal: $USD 0
View My Cart
    • Product Name: Tesamorelin 2mg/vial 5mg/vial
    • Item NO.: 4581522
    • Weight: 0 kg = 0.0000 lb = 0.0000 oz
    • Category: Peptides
    • Creation Time: 2025-07-10
    • including shipping fee.
    • China to UK, by special line+Royal Mail delivery, 7-10 days
    • China to European Union, by special line+DHL,/UPS delivery, 10 days.
    • China to USA, Canada etc, by special line+USPS/Fedex delivery, 10-15 days.

    TESAMORELIN AND THE PITUITARY GLAND
    Tesamorelin might potentially interact with the pituitary gland by possibly binding to GHRH receptors, which might initiate a sequence of molecular events. Researchers propose that it may cause structural alterations in the receptor, thereby activating intracellular signaling pathways. They have noted that this binding process is likely followed by a significant conformational change, involving the transmembrane helix 6 (TM6), which may open the intracellular face for G protein coupling. One potential pathway might involve the stimulation of cyclic adenosine monophosphate (cAMP) production within pituitary cells. This might be achieved through the activation of the enzyme adenylate cyclase, which may convert ATP (adenosine triphosphate) to cAMP. It is suggested that increased cAMP levels might activate protein kinase A (PKA), leading to protein phosphorylation and GHRH receptor activation by Tesamorelin. This cascade might stimulate the synthesis and secretion of growth hormone (hGH) from somatotrophs in the pituitary gland. Research indicates that Tesamorelin may induce up to a 69% rise in overall growth hormone levels, as measured by the 12-hour area under the curve (AUC), which quantifies the total hormone concentration over 12 hours. Additionally, there may be approximately a 55% increase in the average pulse area of growth hormone, which reflects the amount of hormone released during each pulse. Furthermore, levels of insulin-like growth factor 1 (IGF-1) apparently surged by 122%.